Technology
Health
Biotechnology
Aptevo
$0.7989876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.798
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.001 (-0.13%) Today
+$0.0089 (1.13%) After Hours
Why Robinhood?
You can buy or sell Aptevo and other stocks, options, ETFs, and crypto commission-free!
About
Aptevo Therapeutics Inc. Common Stock, also called Aptevo, is a biotechnology company, which engages in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics to improve patients lives. Read More Its pipeline includes APVO210, APVO436, ROR1 Candidate, and ALG.APV-527. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.
Employees
118
Headquarters
Seattle, Washington
Founded
2016
Market Cap
35.58M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
274.89K
High Today
$0.7998
Low Today
$0.765
Open Price
$0.797
Volume
272.71K
52 Week High
$5.97
52 Week Low
$0.67
Collections
Technology
Health
Biotechnology
Therapy
2016 IPO
US
North America
News
Yahoo FinanceMay 9
Aptevo Therapeutics Reports First Quarter 2019 Financial Results
Achieves 73% Increase in First Quarter 2019 Year-Over-Year IXINITY® Net Revenue On Target for Launch of New 3,000 IU IXINITY Assay Mid-2019 Advances Enrollment in APVO436 and APVO210 Phase 1 Clinical Studies; Anticipates Top-Line Preliminary Data Read-outs in the Third and Fourth Quarters of 2019 SEATTLE, May 09, 2019 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (APVO), a biotechnology company focused on developing novel oncology, autoimmune and hematology therapeutics, today provided a business review...
Price Paid on Robinhood
30% Lower
Right Now
52 Week Low
$0.67
Average Price Paid
$1.13
52 Week High
$5.97
Earnings
-$0.63
-$0.53
-$0.42
-$0.32
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.44 per share
Actual
-$0.44 per share